![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Esteve Quimica S.a. Barcelona Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Pantoprazole sodium sesquihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-045 - Rev 02
This Chemical Type CEP, issued on August 13, 2018, remains in force until May 28, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2296 associated with this CEP further emphasizes